Trial Radar AI | ||
|---|---|---|
Clinical Trial NCT06440330 (DECODE) for Post-transplant Diabetes Mellitus, Kidney Transplant; Complications is recruiting. See the Trial Radar Card View and AI discovery tools for all the details. Or ask anything here. | ||
One study matched filter criteria
Card View
Define Predictors for Posttransplant Diabetes Mellitus Study (DECODE) 330
Clinical Trial NCT06440330 (DECODE) is an observational study for Post-transplant Diabetes Mellitus, Kidney Transplant; Complications that is recruiting. It started on 1 September 2023 with plans to enroll 330 participants. Led by University Hospital, Antwerp, it is expected to complete by 30 September 2026. The latest data from ClinicalTrials.gov was last updated on 3 June 2024.
Brief Summary
The primary aim of this prospective, multicentre study is to develop an accurate and convenient tool to predict the risk of PTDM at 3 months post-transplant, based on information on the day of transplantation (day 0).
In order to create such model, we will start by identifying individual predictor variables at the day of transplantation and subsequently explore the optimal combination of these predictors in multivar...
Show MoreOfficial Title
Define Predictors for Posttransplant Diabetes Mellitus Study
Conditions
Post-transplant Diabetes MellitusKidney Transplant; ComplicationsOther Study IDs
- DECODE
- 5469
NCT ID Number
Start Date (Actual)
2023-09-01
Last Update Posted
2024-06-03
Completion Date (Estimated)
2026-09-30
Enrollment (Estimated)
330
Study Type
Observational
Status
Recruiting
Arms / Interventions
| Participant Group/Arm | Intervention/Treatment |
|---|---|
N/A | continuous glucose monitoring continuous glucose monitoring will be used during the first 14 days post-transplantation |
Primary Outcome Measures
| Outcome Measure | Measure Description | Time Frame |
|---|---|---|
Post-transplant diabetes mellitus | Post-transplant diabetes mellitus diagnosis based on the need for glucose lowering therapy or 2h-OGTT value of \>=200mg/dL | at 10-13 weeks post-transplantation |
Participation Assistant
Eligibility Criteria
Eligible Ages
Adult, Older Adult
Minimum Age
18 Years
Eligible Sexes
All
Accepts Healthy Volunteers
Yes
- Adult patients (≥18 years) with end stage kidney disease undergoing kidney transplantation with a deceased or living donor
- Signed informed consent
- Initial therapy with at least tacrolimus and corticosteroids
- Patients with a diagnosis of diabetes mellitus (either type 1 or type 2) prior to kidney transplantation
- Treatment with GLP1-RA for weight losing purposes
- Patients receiving a multi-organ transplantation
- ABO incompatibility
University Hospital, Antwerp- �...
Study Central Contact
Contact: Yassine Laghrib, MD, +3238213435, [email protected]
1 Study Locations in 1 Countries
Antwerpen
UZA, Edegem, Antwerpen, 2650, Belgium
Yassine Laghrib, MD, Contact, +3238213435, [email protected]
Recruiting